Exploring Psilocybin Therapy for Addiction Treatment
Addiction is a complex issue that affects millions of people around the world. It is defined as a chronic and relapsing disorder characterized by compulsive substance use despite harmful consequences. Substance use disorders (SUDs) refer to the clinical diagnosis of addiction, which can include physical dependence on substances such as alcohol, opioids, nicotine, or other drugs. People with SUDs often experience intense cravings and difficulty controlling their intake of substances. They may also struggle with physical and psychological health issues caused by their addiction.
Brief Overview of Current Treatment Options for Addiction
Currently, several evidence-based treatments for SUDs include psychotherapy, behavioral therapy, medications, 12-step programs, mutual help groups, and residential treatment programs. These therapies have been shown to be effective in helping individuals reduce or eliminate their substance use. However, many people find these treatments difficult to access, or they do not work well for them due to various factors such as cost or lack of availability in certain areas.
The Science Behind Psilocybin and Addiction
Psilocybin is a naturally occurring compound found in certain species of mushrooms that have been used for centuries in spiritual ceremonies and rituals around the world. In recent years, research has suggested that psilocybin may be an effective tool in treating SUDs due to its ability to reduce anxiety and depression while increasing feelings of joy and connectedness [1]. While more research is needed to confirm these findings, early results suggest that psilocybin could be a promising option for those seeking alternative addiction treatments.
Previous Research on the Use of Psilocybin for Addiction Treatment
Several studies have explored the potential benefits of using psilocybin therapy for treating SUDs.
In a 2015 study highlighted in the Journal of Psychopharmacology, scientists found that psilocybin might be a game-changer in treating alcohol addiction. The study explains how psilocybin has been used to tackle various mental health issues, including addictive behaviors in the past and suggests that the experiences induced by psilocybin, when guided by professional therapists, could help patients make meaningful mental shifts that combat alcohol dependence. The potential of psilocybin therapy in the fight against alcohol addiction is quite promising, according to the study [2].
The Effectiveness of Psilocybin Therapy for Addiction
Research into psilocybin therapy for addiction has been ongoing since the 1960s when psychedelics were first studied in clinical trials. More recently, a growing body of evidence suggests that psilocybin may be an effective tool for treating substance abuse disorders.
For example, in a recent clinical trial conducted at two academic centers in the US, psilocybin demonstrated promise in treating alcohol use disorder (AUD) when combined with psychotherapy. During the 32-week double-blind study, 95 participants aged 25 to 65, who had been diagnosed with alcohol dependence, were randomly assigned to receive either psilocybin or diphenhydramine, alongside a structured 12-week psychotherapy program. The primary metric assessed was the percentage of heavy drinking days. Remarkably, the psilocybin group experienced a substantial reduction, averaging 9.7% heavy drinking days compared to 23.6% in the diphenhydramine group [3].
Moreover, the psilocybin group also reported a lower daily alcohol consumption. Importantly, no serious adverse events were linked to psilocybin. These encouraging results support further investigation into psilocybin-assisted treatment for AUD.
Comparison to Other Treatment Options for Addiction
Research suggests that psilocybin-assisted psychotherapy may provide greater long-term benefits with fewer side effects compared to other treatments for SUD and AUD, such as cognitive behavioral therapy or medications.
For example, in a pilot study, researchers explored the potential of psilocybin, a psychedelic substance, to help people quit smoking. Fifteen smokers participated in this 15-week study, where they were given moderate and high doses of psilocybin alongside a structured smoking cessation program. The results were surprising - 6 months later, 80% of the participants had not smoked for at least seven days. This is more than double the success rate typically seen with other quit-smoking methods [4].
While this was just a small, initial study and doesn’t prove for sure that psilocybin is a silver bullet, it does suggest that it might be a powerful tool in helping people to kick the habit. This opens the door for more research to be done in this area.
Process of Psilocybin Therapy for Addiction
Psilocybin therapy typically consists of three stages: preparation, administration, and follow-up sessions. During the preparation stage, patients meet with their therapist to develop an individualized plan based on their needs and goals for treatment. During administration sessions, patients receive either low or moderate doses of psilocybin while being monitored by their therapist throughout the experience. Finally, during follow-up, patients are encouraged to discuss their experience with the therapist and integrate any insights they had during their session into their daily life and recovery.
As research on psychedelics continues to advance, we are likely to see an increase in the use of these substances as therapeutic tools in the near future. With the right guidance and support, psychedelic therapies could be a powerful tool in the fight against mental health issues, providing relief for those who have not found success with traditional treatments.
At Psychly, we are committed to upholding the highest standards in our content creation process. We strive to ensure that all statements presented in our articles are supported by reliable, high-quality sources, such as peer-reviewed studies and reputable academic journals.
- The Psychly Team
- van der Meer, P. B., Fuentes, J. J., Kaptein, A. A., Schoones, J. W., de Waal, M. M., Goudriaan, A. E., Kramers, K., Schellekens, A., Somers, M., Bossong, M. G., & Batalla, A. (2023). Therapeutic effect of psilocybin in addiction: A systematic review. Frontiers in psychiatry, 14, 1134454. https://doi.org/10.3389/fpsyt.2023.1134454
- Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P. C., & Strassman, R. J. (2015). Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. Journal of psychopharmacology (Oxford, England), 29(3), 289–299. https://doi.org/10.1177/0269881114565144
- Bogenschutz, M. P., Ross, S., Bhatt, S., Baron, T., Forcehimes, A. A., Laska, E., Mennenga, S. E., O'Donnell, K., Owens, L. T., Podrebarac, S., Rotrosen, J., Tonigan, J. S., & Worth, L. (2022). Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA psychiatry, 79(10), 953–962. https://doi.org/10.1001/jamapsychiatry.2022.2096
- Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of psychopharmacology (Oxford, England), 28(11), 983–992. https://doi.org/10.1177/0269881114548296